Skip to main content
. 2021 Feb 19;75(11):1540–1554. doi: 10.1038/s41430-021-00875-9

Table 1.

Summary of trial characteristics.

Characteristica
Trial comparisons 103
Participants 538
Follow-up duration, minutes 120 (60–240)
Participant characteristics
 • Age, years 37 (22–66)
 • Male:femaleb (%) 50:50
 • BMI, kg/m2 24.9 (20.6–31.1)
Health Status, # of trial comparisons
 • Healthy 77
 • Type 2 Diabetes 11
 • Overweight 9
 • Mixed (Health & Overweight) 5
 • Metabolic Syndrome 1
Intervention characteristics
 • OBG dose, g 4.2 (0.2–11.7)
 • OBG dose, g/30 g available carbohydrates 2.8 (0.1–22.6)
 • Food source, # of trials
⚬ OBG-enriched/oat bran muffins 23
⚬ OBG/oat bran added to glucose/dextrose 20
⚬ OBG-enriched/oat bran cereal 13
⚬ OBG-enriched/oat bran added to oatmeal porridge 13
⚬ Oat granola/muesli with oat bran flakes 10
⚬ OBG-enriched bread 8
⚬ OBG-enriched/oat bran snack bar or product 7
⚬ OBG-enriched/oat bran beverage (juice, shake, drink) 7
⚬ Oat bran pasta 2
• Available carbohydrate, g 50 (13–75)
Comparator characteristics
• Type
 ⚬ Matched 66
 ⚬ Unmatched 37
• Food source, # of trial comparisons
 ⚬ Glucose/dextrose/maltodextrin solution 32
 ⚬ White bread 21
 ⚬ Muffin 16
 ⚬ Wheat porridge or oatmeal without added OBG 12
 ⚬ Wheat granola/muesli with cornflakes 7
 ⚬ Snack bar/product 5
 ⚬ Cornflakes cereal 4
 ⚬ Juice/shake/drink 4
 ⚬ Durum wheat pasta 2
• Available carbohydrate, g 50 (13–75)
Setting, # of trial comparisons
 • North America 70
 • Europe 25
 • South America 4
 • Australia 3
 • Asia 1
Funding source, # of trial comparisonsc
 • Agency 43
 • Industry 28
 • Agency & Industry 9
 • Not reported 23

OBG oat β-glucan, BMI body mass index.

aMedian (range) of mean data, unless otherwise indicated.

b30/31 studies provided data on sex.

cAgency funding is that from government, university, or not-for-profit sources. Industry funding is that from trade organizations that obtain revenue from the sale of products.